One molecule to block both pain and itch

An antibody that specifically blocks the NaV1.7 voltage-gated sodium channel and suppresses pain in mice has surprisingly been found to also suppress itching in mice, even though pain and itch sensations usually follow different paths. Credit: Illustration: Seok-Yong Lee and Ben Chung, Duke University

Duke University researchers have found an antibody that simultaneously blocks the sensations of pain and itching in studies with mice.

The new antibody works by targeting the voltage-sensitive sodium channels in the cell membrane of neurons. The results appear online on May 22 in Cell.

Voltage-sensitive sodium channels control the flow of through the neuron's membrane. These channels open and close by responding to the electric current or action potential of the cells. One particular type of sodium channel, called the Nav1.7 subtype, is responsible for sensing pain.

Mutations in the human gene encoding the Nav1.7 sodium channel can lead to either the inability to sense pain or pain hypersensitivity. Interestingly, these mutations do not affect other sensations such as touch or temperature. Hence, the Nav1.7 sodium channel might be a very specific target for treating pain disorders without perturbing the patients' ability to feel other sensations.

"Originally, I was interested in isolating these sodium channels from cells to study their structure," said Seok-Yong Lee, assistant professor of biochemistry in the Duke University Medical School and principal investigator of the study. He designed that would capture the sodium channels so that he could study them. "But then I thought, what if I could make an antibody that interferes with the channel function?"

The team first tested the antibody in cultured cells engineered to express the Nav1.7 . They found that the antibody can bind to the channel and stabilize its closed state.

"The channel is off when it is closed," Lee explained. "Since the antibody stabilizes the closed state, the channel becomes less sensitive to pain." If this held true in live animals, then the animals would also be less sensitive to pain.

To test this idea, Lee sought the help of Ru-Rong Ji, professor of anesthesiology and neurobiology, who is an expert in the study of pain and sensation. Using laboratory mouse models of inflammatory and , they showed that the antibody can target the Nav1.7 channel and reduce the in these mice. More importantly, mice receiving the treatment did not show signs of physical dependence or enhanced tolerance toward the antibody.

"Pain and itch are distinct sensations, and pain is often known to suppress itch", said Ji.

The team found that the antibody can also relieve acute and chronic itch in mouse models, making them the first to discover the role of Nav1.7 in transmitting the itch sensation.

"Now we have a compound that can potentially treat both pain and itch at the same time," said Lee. Both of these symptoms are common in allergic contact dermatitis, which affects more than 10 million patients a year in the United States alone.

The team is pursuing a patent for the antibody.

"We hope our discovery will garner interest from pharmaceutical companies that can help us expand our studies into clinical trials," Lee said. Their goal is to develop a safer treatment for and itch as an alternative to opioids, which often cause addiction and other detrimental side effects.

More information: "A monoclonal antibody that targets a Nav1.7 channel voltage sensor for pain and itch relief," Jun-Ho Lee, Chul-Kyu Park, Gang Chen, Qingjian Han, Rou-Gang Xie, Tong Liu, Ru-Rong Ju and Seok-Yong Lee. Cell, May 23, 2014.

add to favorites email to friend print save as pdf

Related Stories

A common thread: No pain, no smell

Mar 25, 2011

(PhysOrg.com) -- In a recent study published in Nature by Jan Weiss and Frank Zufall of the University of Saarland, School of Medicine, a connection has been made between the inability to feel pain and anosmia - the inabil ...

New insight into pain mechanisms

Apr 25, 2012

(Medical Xpress) -- Researchers in the UCL Wolfson Institute for Biomedical Research have made a discovery which could help the development of analgesic drugs able to treat nerve damage-related pain.

Study: Why cold is such a pain

Jun 14, 2007

German scientists have identified a key molecule that helps animals feel pain associated with low temperatures.

Recommended for you

A novel therapy for sepsis?

13 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments